Home Contact Us

About Us

About Us

About Alkermes

Our Company Message From the CEO Locations

Leadership

Management Team Board of Directors

Collaborations

Strategic Partners

Products

Products

Products

Products Overview

United States

ARISTADA ^® VIVITROL ^®Proprietary Products and Technologies Wholesaler and Purchasing Information

European Union

EU Products Using Alkermes Technologies

Research & Development

Research & Development

Research & Development

R&D Overview Our R&D Approach Pipeline Technology Platforms Manufacturing

Other Information

Clinical Trials Expanded Access

Responsibility

Responsibility

Responsibility

Corporate Responsibility Corporate Giving and Funding Alkermes Inspiration Grants^® COVID-19 Relief Fund Medical Education Grants Alkermes Pathways Research Awards^® Investigator Sponsored Studies Public Policy

Investors

Investors

Investors

Corporate Overview Press Releases Investor Events Stock Information SEC Filings Annual Reports

Financials

Snapshot Trading Statistics

Other Information

Email Alerts

News & Events

News & Events

News & Events

Press Releases Media Kit

Careers

Careers

Careers

Working Together Our Core Values Total Rewards Meet Our Employees Recruiting Agencies Equal Opportunity Employer Jobs Overview

Job Opportunities

Field Sales Roles All Available Roles

Investors

Corporate Overview Press Releases Investor Events Stock Information SEC Filings Annual Reports

Financials

Snapshot Trading Statistics

Other Information

Email Alerts

SEC Filings

Print Page

Print Page

E-mail Page

Email Page

RSS

E-mail Alerts

Email Alerts

Financial Tear Sheet

Tear Sheet

SEC Filings

Filing date	Form	Description
03/26/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-011999.pdf 0001127602-20-011999.rtf 0001127602-20-011999.xls View HTML
03/26/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-012000.pdf 0001127602-20-012000.rtf 0001127602-20-012000.xls View HTML
03/19/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-011504.pdf 0001127602-20-011504.rtf 0001127602-20-011504.xls View HTML
03/19/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-011503.pdf 0001127602-20-011503.rtf 0001127602-20-011503.xls View HTML
03/03/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-008982.pdf 0001127602-20-008982.rtf 0001127602-20-008982.xls View HTML
03/03/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-008995.pdf 0001127602-20-008995.rtf 0001127602-20-008995.xls View HTML
03/03/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-009010.pdf 0001127602-20-009010.rtf 0001127602-20-009010.xls View HTML
03/03/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-009019.pdf 0001127602-20-009019.rtf 0001127602-20-009019.xls View HTML
03/03/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-009029.pdf 0001127602-20-009029.rtf 0001127602-20-009029.xls View HTML
02/25/20	4	Statement of changes in beneficial ownership of securities	3,4,5	0001127602-20-007701.pdf 0001127602-20-007701.rtf 0001127602-20-007701.xls View HTML

Data provided by Kaleidoscope.